ResearcherHarold C. Simmons Comprehensive Cancer CenterActive in the last 2 years
Sandi L. Pruitt
Matched on ORCID iD 0000-0002-1007-9176; OpenAlex author ID A5042216129. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: none · 2023: 1 paper · 2024: 1 paper
Papers 6
- Accessibility to ERCP-performing hospitals among patients with pancreatic cancer living in SEER regions. Last author DOI 10.1002/cam4.7020↗
- Survival of cancer survivors with a new pancreatic cancer diagnosis. Co-author DOI 10.1002/cam4.4903↗
- Survival analysis among unresectable pancreatic adenocarcinoma patients undergoing endoscopic or percutaneous interventions. Co-author DOI 10.1016/j.gie.2020.05.061↗
- Early Palliative Care Is Associated With Reduced Emergency Department Utilization in Pancreatic Cancer. Co-author DOI 10.1097/coc.0000000000000802↗
- Racial Disparities and Trends in Pancreatic Cancer Incidence and Mortality in the United States. Co-author DOI 10.1016/j.cgh.2019.05.059↗
- Regional and racial variations in the utilization of endoscopic retrograde cholangiopancreatography among pancreatic cancer patients in the United States. Co-author DOI 10.1002/cam4.2225↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Anna Tavakkoli · 6 shared papers, 2019–2024 · strength 0.81
- Paper Accessibility to ERCP-performing hospitals among patients with pancreatic cancer living in SEER regions. DOI 10.1002/cam4.7020↗
- Paper Survival of cancer survivors with a new pancreatic cancer diagnosis. DOI 10.1002/cam4.4903↗
- Paper Survival analysis among unresectable pancreatic adenocarcinoma patients undergoing endoscopic or percutaneous intervent… DOI 10.1016/j.gie.2020.05.061↗
- Amit G. Singal · 5 shared papers, 2019–2024 · strength 0.70
- Paper Accessibility to ERCP-performing hospitals among patients with pancreatic cancer living in SEER regions. DOI 10.1002/cam4.7020↗
- Paper Survival of cancer survivors with a new pancreatic cancer diagnosis. DOI 10.1002/cam4.4903↗
- Paper Survival analysis among unresectable pancreatic adenocarcinoma patients undergoing endoscopic or percutaneous intervent… DOI 10.1016/j.gie.2020.05.061↗
- B. Joseph Elmunzer · 4 shared papers, 2019–2024 · strength 0.52
- Paper Accessibility to ERCP-performing hospitals among patients with pancreatic cancer living in SEER regions. DOI 10.1002/cam4.7020↗
- Paper Survival analysis among unresectable pancreatic adenocarcinoma patients undergoing endoscopic or percutaneous intervent… DOI 10.1016/j.gie.2020.05.061↗
- Paper Racial Disparities and Trends in Pancreatic Cancer Incidence and Mortality in the United States. DOI 10.1016/j.cgh.2019.05.059↗
- Caitlin C. Murphy · 4 shared papers, 2019–2023 · strength 0.49
- Paper Survival of cancer survivors with a new pancreatic cancer diagnosis. DOI 10.1002/cam4.4903↗
- Paper Survival analysis among unresectable pancreatic adenocarcinoma patients undergoing endoscopic or percutaneous intervent… DOI 10.1016/j.gie.2020.05.061↗
- Paper Racial Disparities and Trends in Pancreatic Cancer Incidence and Mortality in the United States. DOI 10.1016/j.cgh.2019.05.059↗
- James M. Scheiman · 3 shared papers, 2019–2021 · strength 0.32
- Paper Survival analysis among unresectable pancreatic adenocarcinoma patients undergoing endoscopic or percutaneous intervent… DOI 10.1016/j.gie.2020.05.061↗
- Paper Racial Disparities and Trends in Pancreatic Cancer Incidence and Mortality in the United States. DOI 10.1016/j.cgh.2019.05.059↗
- Paper Regional and racial variations in the utilization of endoscopic retrograde cholangiopancreatography among pancreatic ca… DOI 10.1002/cam4.2225↗
- Muhammad Shaalan Beg · 2 shared papers, 2021–2023 · strength 0.29
- Jack Bevins · 1 shared paper, 2021 · strength 0.12
- Nizar Bhulani · 1 shared paper, 2021 · strength 0.12
- Nina Niu Sanford · 1 shared paper, 2021 · strength 0.12
- Syed Mohammad Ali Kazmi · 1 shared paper, 2021 · strength 0.12
- Hari Nathan · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.